Related to UCB and Plasticell Partner to Identify Compounds for SC Research and Cell Therapeutics

• CDC to Use Automation Partnership's CompacT SelecT Cell Culture System
  
• Agenta Wins $1.1M SBIR Grant to Develop Regenerative Membrane for Oral Surgery
  
• First Patient Receives ReNeuron’s Neural Stem Cell Therapy
  
• Stem Cell Environment Created that Provides Chemical, Electrical, and Mechanical Cues
  
• EMA Launches Program to Help Firms with Advanced Therapeutics Negotiate Regulatory Maze
  
• DiscoveRx Takes Over KINOMEscan™ from Ambit Biosciences
  
• Team Generates 3-D Epithelial Tumors In Vitro from Normal Human Primary Cells
  
• Investigators Find New Method to Create Mesenchymal-Like Stem Cells
  
• LGC Signs Up as First Distributor for Reinnervate’s 3-D Cell Culture Scaffold
  
• CIRM Gains Access to Five of BioTime’s ESC Lines
  
• Cell Trends and Texcell Couple Biotherapeutic Safety Testing Services
  
• Takeda Snags Exclusive License to Baxter’s Vero Cell Culture Tech for Flu Vaccine
  
• MedImmune Nabs Evotec’s Beta Cell Regeneration Portfolio for €5M Up Front
  
• Pathfinder and SyntheMed Merge to Develop Regenerative Therapies for Organ Damage
  
• Merck KGaA Buys Chinese Cell Culture Media Firm Beijing Skywing for About $18.8M
  
• EHSI Forms JV to Evaluate a Regenerative Medicine Method
  
• Animal-Free Culture System for Single-Cell Passaging of hESCs Developed
  
• Agilent Takes Over Lab901 and Biocius Life Sciences
  
• Scientists Generate Alzheimer-Relevant Neurons from hESCs and iPSCs
  
• Fibrocell and UCLA Partner to Develop Autologous Cell Regenerative Therapies